Differences Between Benign and Malignant Tumors

Dec 29, 2021 Source: Cainiu Health
Dr. Liu Dahai
Introduction
Differences Between Benign and Malignant Tumors: I. Benign tumors are tumors lacking invasive and metastatic potential. They are typically encapsulated or well-demarcated, grow expansively, proliferate slowly, and consist of well-differentiated tumor cells; thus, they pose relatively little harm to the body. II. Malignant tumors can be histologically classified into two categories: carcinomas—arising from malignant transformation of epithelial cells—and sarcomas—arising from malignant transformation of mesenchymal tissue.

Most people fear the development of tumors and are reluctant to confront such a diagnosis. Currently, tumor incidence rates are high. Tumors may be either benign or malignant; malignant tumors constitute cancers, whereas benign tumors generally pose relatively less threat to patients. Below, we outline the key differences between benign and malignant tumors.

Differences Between Benign and Malignant Tumors

I. Benign Tumors

Benign tumors lack invasive and metastatic potential. They typically possess a well-defined capsule or clear margins and grow expansively—slowly and in a non-infiltrative manner. Their cells are well-differentiated and mature, thus posing minimal harm to the body. A benign tumor arises from abnormal proliferation of certain tissue cells within the body, expanding gradually like an inflating balloon, with relatively slow growth.

As the tumor enlarges, it may compress surrounding tissues but does not invade adjacent normal tissues. It commonly appears spherical or nodular, often surrounded by a fibrous capsule, resulting in a distinct boundary with neighboring healthy tissue. On physical examination, it is usually mobile upon palpation. Surgical excision is typically straightforward and complete, with no metastasis and rare recurrence.

II. Malignant Tumors

Histologically, malignant tumors fall into two main categories: (1) carcinomas—arising from malignant transformation of epithelial cells (e.g., lung epithelial cells giving rise to lung cancer, gastric epithelial cells to gastric cancer); and (2) sarcomas—originating from malignant transformation of mesenchymal tissues (e.g., leiomyosarcoma, fibrosarcoma). Carcinomas are more commonly discussed than sarcomas, largely because carcinoma patients vastly outnumber sarcoma patients; clinically, the ratio of carcinomas to sarcomas is approximately 9:1.

Symptoms of Benign Tumors

1. Headache
Approximately 80% of patients experience headache, which is the most common early symptom—though not definitive for diagnosis. Any factor that increases intracranial pressure may exacerbate headache intensity.

2. Vomiting
Vomiting is unrelated to food intake and frequently occurs in the early morning. It commonly accompanies severe headache and may present as projectile vomiting; however, non-projectile vomiting is also frequently observed.

3. Visual Impairment
In early stages, benign tumor patients may exhibit no visual disturbance; however, over time, progressive constriction of the visual field may occur, ultimately leading to decreased visual acuity.

The above outlines the principal distinctions between benign and malignant tumors. We hope this information proves helpful.